SIM
VYNT

Spark Investment Management’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Spark Investment Management’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-77
Closed -$19K – 754
2018
Q1 		$19K Buy
+77
New +$21.7K ﹤0.01% 594
2016
Q1 		– Sell
-89
Closed -$43K – 862
2015
Q4 		$43K Buy
+89
New +$64.3K 0.01% 722

Other funds holding VYNT

SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

Spark Investment Management's VYNT Position: Q2 2018 in Review

Spark Investment Management sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2018, closing a stake of 77 shares — an estimated $19K sold.

Spark Investment Management first reported a position in VYNT in Q4 2015 and held it in 2 quarters. The position peaked at $43K in Q4 2015. 23 funds tracked by Wall St. Rank hold VYNT as of Q2 2018.

  • Spark Investment Management reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Spark Investment Management sold 77 Vyant Bio, Inc. Common Stock shares in Q2 2018, an estimated $19K.
  • Spark Investment Management first reported a position in Vyant Bio, Inc. Common Stock in Q4 2015 and held it in 2 quarters.
  • Spark Investment Management's Vyant Bio, Inc. Common Stock position peaked at $43K in Q4 2015.
  • 23 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2018.

Based on Spark Investment Management's 13F filing for Q2 2018, filed 8 Aug 2018.